These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26906163)

  • 1. Treatment of Congenital Toxoplasmosis: Safety of the Sulfadoxine-Pyrimethamine Combination in Children Based on a Method of Causality Assessment.
    Teil J; Dupont D; Charpiat B; Corvaisier S; Vial T; Leboucher G; Wallon M; Peyron F
    Pediatr Infect Dis J; 2016 Jun; 35(6):634-8. PubMed ID: 26906163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Congenital toxoplasmosis. Tolerability of the sulfadoxine-pyrimethamine combination. 24 cases].
    Maisonneuve H; Faber C; Piens MA; Garin JP
    Presse Med; 1984 Mar; 13(14):859-62. PubMed ID: 6231609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group.
    Villena I; Aubert D; Leroux B; Dupouy D; Talmud M; Chemla C; Trenque T; Schmit G; Quereux C; Guenounou M; Pluot M; Bonhomme A; Pinon JM
    Scand J Infect Dis; 1998; 30(3):295-300. PubMed ID: 9790140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.
    Aponte JJ; Schellenberg D; Egan A; Breckenridge A; Carneiro I; Critchley J; Danquah I; Dodoo A; Kobbe R; Lell B; May J; Premji Z; Sanz S; Sevene E; Soulaymani-Becheikh R; Winstanley P; Adjei S; Anemana S; Chandramohan D; Issifou S; Mockenhaupt F; Owusu-Agyei S; Greenwood B; Grobusch MP; Kremsner PG; Macete E; Mshinda H; Newman RD; Slutsker L; Tanner M; Alonso P; Menendez C
    Lancet; 2009 Oct; 374(9700):1533-42. PubMed ID: 19765816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
    Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
    Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
    Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
    Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malaria pharmacovigilance in Africa: lessons from a pilot project in Mpumalanga Province, South Africa.
    Mehta U; Durrheim D; Mabuza A; Blumberg L; Allen E; Barnes KI
    Drug Saf; 2007; 30(10):899-910. PubMed ID: 17867727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prenatal treatment of congenital toxoplasmosis].
    Chemla C; Villena I; Trenque T; Pinon JM;
    Presse Med; 2005 Dec; 34(22 Pt 1):1719. PubMed ID: 16374395
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of the efficacy of artesunate plus sulfadoxine-pyrimethamine with that of sulfadoxine-pyrimethamine alone, in the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.
    Adam I; A-Elbasit IE; Idris SM; Malik EM; Elbashir MI
    Ann Trop Med Parasitol; 2005 Jul; 99(5):449-55. PubMed ID: 16004704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of artesunate plus sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine alone for the treatment of uncomplicated Plasmodium falciparum malaria in Peru.
    Marquiño W; Ylquimiche L; Hermenegildo Y; Palacios AM; Falconí E; Cabezas C; Arróspide N; Gutierrez S; Ruebush TK
    Am J Trop Med Hyg; 2005 May; 72(5):568-72. PubMed ID: 15891131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine.
    Briand V; Bottero J; Noël H; Masse V; Cordel H; Guerra J; Kossou H; Fayomi B; Ayemonna P; Fievet N; Massougbodji A; Cot M
    J Infect Dis; 2009 Sep; 200(6):991-1001. PubMed ID: 19656069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intermittent preventive treatment for malaria during infancy on serological responses to measles and other vaccines used in the Expanded Programme on Immunization: results from five randomised controlled trials.
    Crawley J; Sismanidis C; Goodman T; Milligan P;
    Lancet; 2012 Sep; 380(9846):1001-10. PubMed ID: 22850358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Maternal pancytopenia during antenatal treatment of congenital toxoplasmosis].
    Mubiayi N; Coutty N; Detourmignies L; Le Goueff F; Decocq J; Delahousse G
    Presse Med; 2004 Aug; 33(14 Pt 1):930-3. PubMed ID: 15509046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transplacental passage of the pyrimethamine-sulfadoxine combination in the prenatal treatment of congenital toxoplasmosis].
    Dorangeon P; Fay R; Marx-Chemla C; Leroux B; Harika G; Dupouy D; Quereux C; Choisy H; Pinon JM; Wahl P
    Presse Med; 1990 Dec 22-29; 19(44):2036. PubMed ID: 2148622
    [No Abstract]   [Full Text] [Related]  

  • 15. [The risks of pyrimethamine-sulfadoxine combination in the prenatal treatment of toxoplasmosis].
    Dorangeon PH; Marx-Chemla C; Quereux C; Fay R; Leroux B; Choisy H; Pinon JM; Wahl P
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(5):549-56. PubMed ID: 1401771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance for adverse drug reactions to combination antimalarial therapy with sulfadoxine-pyrimethamine plus artesunate in Peru.
    Cairo J; Durand S; Marquiño W; Cabezas C; Lachira A; Quintana F; Vegas W; Ruebush TK; Utz G; Bacon DJ
    Am J Trop Med Hyg; 2008 Jul; 79(1):42-4. PubMed ID: 18606762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants.
    Kobbe R; Kreuzberg C; Adjei S; Thompson B; Langefeld I; Thompson PA; Abruquah HH; Kreuels B; Ayim M; Busch W; Marks F; Amoah K; Opoku E; Meyer CG; Adjei O; May J
    Clin Infect Dis; 2007 Jul; 45(1):16-25. PubMed ID: 17554695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis.
    Trenque T; Simon N; Villena I; Chemla C; Quereux C; Leroux B; Jaussaud R; Rémy G; Dupouy D; Millart H; Pinon JM; Urien S
    Br J Clin Pharmacol; 2004 Jun; 57(6):735-41. PubMed ID: 15151519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacies of artesunate plus either sulfadoxine-pyrimethamine or amodiaquine, for the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.
    Ibrahium AM; Kheir MM; Osman ME; Khalil IF; Alifrangis M; Elmardi KA; Malik EM; Adam I
    Ann Trop Med Parasitol; 2007 Jan; 101(1):15-21. PubMed ID: 17244406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.